UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cannabis use and psychosis: a review of reviews

European archives of psychiatry and clinical neuroscience, 2020-06, Vol.270 (4), p.403-412

2020

Volltextzugriff (PDF)

Anandamide dysfunction in prodromal and established psychosis

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5188-5193

Leweke, F Markus

2012

Volltextzugriff (PDF)

Right care, first time: a highly personalised and measurement‐based care model to manage youth mental health

Medical journal of Australia, 2019-11, Vol.211 (S9), p.S3-S46

2019

Volltextzugriff (PDF)

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

eLife, 2018-09, Vol.7

2018

Volltextzugriff (PDF)

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Schizophrenia research, 2013-08, Vol.148 (1), p.130-137

2013

Volltextzugriff (PDF)

Obituary for Professor Hinderk Meiners Emrich, MD PhD

European archives of psychiatry and clinical neuroscience, 2018-12, Vol.268 (8), p.873-874

2018

Volltextzugriff (PDF)

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Frontiers in pharmacology, 2021-04, Vol.12, p.614811-614811

2021

Volltextzugriff (PDF)

Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

Frontiers in psychiatry, 2023-03, Vol.14, p.1088459

2023

Volltextzugriff (PDF)

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

Frontiers in psychiatry, 2022-05, Vol.13, p.885904-885904

2022

Volltextzugriff (PDF)

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

Schizophrenia research, 2013-11, Vol.150 (2), p.519-525

2013

Volltextzugriff (PDF)

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

CNS drugs, 2018-07, Vol.32 (7), p.605-619

2018

Volltextzugriff (PDF)

ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids

Scientific reports, 2024-02, Vol.14 (1), p.4375-4375, Article 4375

2024

Volltextzugriff (PDF)

Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats

Addiction biology, 2020-05, Vol.25 (3), p.e12745-n/a

2020

Volltextzugriff (PDF)

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Neuropsychopharmacology, 2004-11, Vol.29 (11), p.2108-2114

2004

Volltextzugriff (PDF)

Distinct molecular phenotypes in male and female schizophrenia patients

PloS one, 2013-11, Vol.8 (11), p.e78729-e78729

2013

Volltextzugriff (PDF)

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

Schizophrenia research, 2017-05, Vol.183, p.64-69

2017

Volltextzugriff (PDF)

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients

European archives of psychiatry and clinical neuroscience, 2019-12, Vol.269 (8), p.897-910

2019

Volltextzugriff (PDF)

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers

Frontiers in psychiatry, 2021-03, Vol.12, p.654602-654602

2021

Volltextzugriff (PDF)

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats

Frontiers in behavioral neuroscience, 2016-07, Vol.10, p.148-148

2016

Volltextzugriff (PDF)

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

British journal of psychiatry, 2009-04, Vol.194 (4), p.371-372

2009

Volltextzugriff (PDF)

Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial

BMJ open, 2022-09, Vol.12 (9), p.e056298-e056298

2022

Volltextzugriff (PDF)

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

Schizophrenia research, 2007-08, Vol.94 (1), p.29-36

2007

Volltextzugriff (PDF)

Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density

Translational psychiatry, 2023-10, Vol.13 (1), p.325-325, Article 325

2023

Volltextzugriff (PDF)

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

Brain, behavior, and immunity, 2015-02, Vol.44, p.148-158

2015

Volltextzugriff (PDF)

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

PLoS medicine, 2006-08, Vol.3 (8), p.e327-e327

2006

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(163)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(112)
Humans
(98)
Psychiatry
(94)
Male
(72)
Schizophrenia
(67)
Female
(65)
Adult
(64)
Neurosciences
(41)
Neurosciences & Neurology
(40)
Young Adult
(34)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Middle Aged
(25)
Pharmacology & Pharmacy
(24)
Mental Disorders
(23)
Psychosis
(23)
Clinical Neurology
(21)
Medicine
(21)
Psychology. Psychoanalysis. Psychiatry
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cannabis use and psychosis: a review of reviews

Anandamide dysfunction in prodromal and established psychosis

Right care, first time: a highly personalised and measurement‐based care model to manage youth mental health

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Obituary for Professor Hinderk Meiners Emrich, MD PhD

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids

Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Distinct molecular phenotypes in male and female schizophrenia patients

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

Suchergebnisse filtern